Published in Pediatrics on January 01, 1996
Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J Virol (2001) 2.06
The future of research into rotavirus vaccine. BMJ (2000) 1.70
Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999. J Clin Microbiol (2001) 1.68
The paediatric burden of rotavirus disease in Europe. Epidemiol Infect (2006) 1.60
Immunology of gut mucosal vaccines. Immunol Rev (2011) 1.59
Rotavirus vaccines: an overview. Clin Microbiol Rev (2008) 1.58
Gastroenterology in developing countries: issues and advances. World J Gastroenterol (2009) 1.53
Rotavirus vaccine withdrawal in the United states; the role of postmarketing surveillance. Can J Infect Dis (2000) 1.47
Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin (2010) 1.39
Great diversity of group A rotavirus strains and high prevalence of mixed rotavirus infections in India. J Clin Microbiol (2001) 1.36
Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles. J Virol (1999) 1.22
Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol (1999) 1.18
Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season. J Clin Microbiol (2004) 1.13
M cell-targeted DNA vaccination. Proc Natl Acad Sci U S A (2001) 1.10
Distribution of human rotavirus G types circulating in Paris, France, during the 1997-1998 epidemic: high prevalence of type G4. J Clin Microbiol (1999) 1.04
Functional mapping of protective domains and epitopes in the rotavirus VP6 protein. J Virol (2000) 1.03
Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines. Biologics (2010) 1.00
Rotavirus vaccines: update on global impact and future priorities. Hum Vaccin (2011) 0.92
Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens. Hum Vaccin Immunother (2012) 0.90
A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis. Eur J Pediatr (2009) 0.89
Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae. Hum Vaccin Immunother (2015) 0.86
Serum rotavirus neutralizing-antibody titers compared by plaque reduction and enzyme-linked immunosorbent assay-based neutralization assays. J Clin Microbiol (1996) 0.85
Evaluating the safety of a rotavirus vaccine: the REST of the story. Clin Trials (2008) 0.84
Increased prevalence of G1P[4] genotype among children with rotavirus-associated gastroenteritis in metropolitan Detroit. J Clin Microbiol (2003) 0.83
The legacy of Edward Jenner. BMJ (1996) 0.82
Vaccines against traveler's diarrhoea and rotavirus disease - a review. Wien Klin Wochenschr (2006) 0.81
Active immunization in the United States: developments over the past decade. Clin Microbiol Rev (2001) 0.80
The link between rotavirus vaccination and intussusception: implications for vaccine strategies. Gut (2002) 0.79
Occurrence of group A rotavirus mixed P genotypes infections in children living in Goiânia-Goiás, Brazil. Eur J Clin Microbiol Infect Dis (2008) 0.79
[Examples for vaccines against diarrheal diseases--rotavirus and traveller's diarrhea]. Wien Med Wochenschr (2007) 0.78
Development of a fluorescent focus identification assay using serotype-specific monoclonal antibodies for detection and quantitation of rotaviruses in a tetravalent rotavirus vaccine. Clin Diagn Lab Immunol (1998) 0.78
Catheter ablation in paediatric arrhythmias. Arch Dis Child (1999) 0.77
Rotavirus: a new vaccine for the UK? Arch Dis Child (1999) 0.75
Design and Antigenic Epitopes Prediction of a New Trial Recombinant Multiepitopic Rotaviral Vaccine: In Silico Analyses. Viral Immunol (2015) 0.75
Rotavirus infections: Is the time right for more changes? Paediatr Child Health (1998) 0.75
Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR. PLoS One (2014) 0.75
Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean. BMC Pediatr (2017) 0.75
Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol (1990) 10.23
Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol (1972) 9.12
Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol (1992) 8.25
Enzyme-linked immunosorbent assay (ELISA) for detection of human reovirus-like agent of infantile gastroenteritis. Lancet (1977) 7.84
Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med (1976) 7.57
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol (1969) 6.85
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A (1985) 5.94
Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science (1973) 5.82
Molecular epidemiology of "Norwalk-like viruses" in outbreaks of gastroenteritis in the United States. J Infect Dis (1998) 5.32
Reoviruslike agent in stools: association with infantile diarrhea and development of serologic tests. Science (1974) 5.32
Human rotavirus type 2: cultivation in vitro. Science (1980) 5.22
Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ (1992) 5.03
Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol (1982) 4.93
Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88
Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med (1977) 4.80
Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med (1978) 4.73
Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A (1981) 4.47
Comparison of human and animal rotavirus strains by gel electrophoresis of viral RNA. Virology (1978) 4.08
Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med (2003) 3.94
Identification of a distinct common strain of "Norwalk-like viruses" having a global distribution. J Infect Dis (1999) 3.88
Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83
Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med (1997) 3.80
Surveillance of patients attending a diarrhoeal disease hospital in Bangladesh. Br Med J (Clin Res Ed) (1982) 3.75
Detection and differentiation of antigenically distinct small round-structured viruses (Norwalk-like viruses) by reverse transcription-PCR and southern hybridization. J Clin Microbiol (1995) 3.69
Rotavirus infections in infants as protection against subsequent infections. N Engl J Med (1996) 3.61
New complement-fixation test for the human reovirus-like agent of infantile gastroenteritis. Nebraska calf diarrhea virus used as antigen. Lancet (1975) 3.56
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol (1994) 3.50
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A (1967) 3.47
Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh. Lancet (1976) 3.38
Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31
Typing of human astroviruses from clinical isolates by enzyme immunoassay and nucleotide sequencing. J Clin Microbiol (1995) 3.30
Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res (1998) 3.30
Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23
Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes. Virology (1987) 3.22
Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis (1996) 3.20
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis (1974) 3.10
ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis (1993) 3.06
Comparison of direct electron microscopy, immune electron microscopy, and rotavirus enzyme-linked immunosorbent assay for detection of gastroenteritis viruses in children. J Clin Microbiol (1981) 3.05
Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol (2000) 3.00
Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97
Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc Natl Acad Sci U S A (1990) 2.90
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis (2000) 2.90
Rotavirus. Emerg Infect Dis (1999) 2.90
Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med (1978) 2.86
Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA (1998) 2.86
Do pili play a role in pathogenicity of Haemophilus influenzae type B? Lancet (1982) 2.84
Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J Infect Dis (1985) 2.78
RNA sequence of astrovirus: distinctive genomic organization and a putative retrovirus-like ribosomal frameshifting signal that directs the viral replicase synthesis. Proc Natl Acad Sci U S A (1993) 2.77
Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J Infect Dis (1998) 2.75
Antigenic relationships among five reovirus-like (RVL) agents by complement fixation (CF) and development of new substitute CF antigens for the human RVL agent of infantile gastroenteritis. Proc Soc Exp Biol Med (1976) 2.74
Pattern of shedding of the Norwalk particle in stools during experimentally induced gastroenteritis in volunteers as determined by immune electron microscopy. J Infect Dis (1975) 2.74
Global seasonality of rotavirus infections. Bull World Health Organ (1990) 2.73
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Correlation of patient immune responses with genetically characterized small round-structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995. J Med Virol (1997) 2.70
Immunological response to infection with human reovirus-like agent: measurement of anti-human reovirus-like agent immunoglobulin G and M levels by the method of enzyme-linked immunosorbent assay. Infect Immun (1978) 2.64
Proteins of Norwalk virus. J Virol (1981) 2.59
Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol (1993) 2.58
Comparative epidemiology of two rotavirus serotypes and other viral agents associated with pediatric gastroenteritis. Am J Epidemiol (1979) 2.56
Cold weather seasonality of gastroenteritis associated with Norwalk-like viruses. J Infect Dis (2000) 2.54
Pediatric viral gastroenteritis during eight years of study. J Clin Microbiol (1983) 2.50
Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol (1985) 2.49
Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections. J Clin Microbiol (1985) 2.47
Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol (1998) 2.44
Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene. J Virol (1988) 2.44
Unusual diversity of human rotavirus G and P genotypes in India. J Clin Microbiol (1996) 2.43
Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation. J Virol (1986) 2.42
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Differentiation of human and calf reoviruslike agents associated with diarrhea using polyacrylamide gel electrophoresis of RNA. Virology (1976) 2.40
Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science (1997) 2.40
Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis (1980) 2.39
Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J Virol (1988) 2.38
Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection. Proc Natl Acad Sci U S A (1986) 2.37
Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology (1997) 2.37
Detection of group B and C rotaviruses by polymerase chain reaction. J Clin Microbiol (1991) 2.36
Enzyme-linked immunosorbent assay for identification of rotaviruses from different animal species. Science (1978) 2.36
A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther (2000) 2.34
Rapid assessment of health status and preventive-medicine needs of newly arrived Kampuchean refugees, Sa Kaeo, Thailand. Lancet (1980) 2.34
Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol (1999) 2.33
More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis (2005) 2.32
T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J Immunol (1998) 2.31
Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J Clin Microbiol (1999) 2.31
Influence of immunological factors in respiratory syncytial virus disease. Arch Environ Health (1970) 2.30
Distribution of serotypes of human rotavirus in different populations. J Clin Microbiol (1992) 2.29
Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol (2005) 2.28
Detection by immune electron microscopy of 26- to 27-nm viruslike particles associated with two family outbreaks of gastroenteritis. J Infect Dis (1977) 2.25
Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis (1998) 2.24
A microtiter solid phase radioimmunoassay for detection of the human reovirus-like agent in stools. J Immunol (1977) 2.24